EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Dipeptidyl Peptidase (DPP)-4 Inhibitors and Pituitary Adenylate Cyclase-Activating Polypeptide, a DPP-4 Substrate, Extend Neurite Outgrowth of Mouse Dorsal Root Ganglia Neurons: A Promising Approach in Diabetic Polyneuropathy Treatment

Masahiro Yamaguchi, Saeko Noda-Asano, Rieko Inoue, Tatsuhito Himeno iD, Mikio Motegi, Tomohide Hayami, Hiromi Nakai-Shimoda, Ayumi Kono, Sachiko Sasajima, Emiri Miura-Yura iD, Yoshiaki Morishita, Masaki Kondo und 6 weitere

International Journal of Molecular Sciences · 2024

DOI: 10.3390/ijms25168881 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Masahiro Yamaguchi und 17 weiteren Autor:innen. Beteiligte Einrichtung: Division of Diabetes, Department of Internal Medicine, Aichi Medical University School of Medicine, Nagakute 480-1185, Japan. Hauptthemen laut MEDLINE: Ganglia, Spinal, Dipeptidyl-Peptidase IV Inhibitors, Pituitary Adenylate Cyclase-Activating Polypeptide, Neuronal Outgrowth. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 65 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Individuals suffering from diabetic polyneuropathy (DPN) experience debilitating symptoms such as pain, paranesthesia, and sensory disturbances, prompting a quest for effective treatments. Dipeptidyl-peptidase (DPP)-4 inhibitors, recognized for their potential in ameliorating DPN, have sparked interest, yet the precise mechanism underlying their neurotrophic impact on the peripheral nerve system (PNS) remains elusive. Our study delves into the neurotrophic effects of DPP-4 inhibitors, including Diprotin A, linagliptin, and sitagliptin, alongside pituitary adenylate cyclase-activating polypeptide (PACAP), Neuropeptide Y (NPY), and Stromal cell-derived factor (SDF)-1a—known DPP-4 substrates with neurotrophic properties. Utilizing primary culture dorsal root ganglia (DRG) neurons, we meticulously evaluated neurite outgrowth in response to these agents. Remarkably, all DPP-4 inhibitors and PACAP demonstrated a significant elongation of neurite length in DRG neurons (PACAP 0.1 μM: 2221 ± 466 μm, control: 1379 ± 420, p < 0.0001), underscoring their potential in nerve regeneration. Conversely, NPY and SDF-1a failed to induce neurite elongation, accentuating the unique neurotrophic properties of DPP-4 inhibition and PACAP. Our findings suggest that the upregulation of PACAP, facilitated by DPP-4 inhibition, plays a pivotal role in promoting neurite elongation within the PNS, presenting a promising avenue for the development of novel DPN therapies with enhanced neurodegenerative capabilities.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Ganglia, SpinalDipeptidyl-Peptidase IV InhibitorsPituitary Adenylate Cyclase-Activating PolypeptideNeuronal OutgrowthDiabetic NeuropathiesAnimalsMiceNeuropeptide YChemokine CXCL12NeuronsLinagliptinDipeptidyl Peptidase 4Sitagliptin PhosphateCells, CulturedNeuritesOligopeptides

Stichwörter der Autor:innen

diabetic polyneuropathydipeptidylpeptidase-4neurite outgrowth of dorsal root ganglia neuronspituitary adenylate cyclase-activating polypeptide

Substanzen

Dipeptidyl-Peptidase IV InhibitorsPituitary Adenylate Cyclase-Activating PolypeptideNeuropeptide YChemokine CXCL12diprotin ALinagliptinDipeptidyl Peptidase 4Sitagliptin PhosphateOligopeptides

Autor:innen und Institutionen

  • Division of Diabetes, Department of Internal Medicine, Aichi Medical University School of Medicine, Nagakute 480-1185, Japan.
  • Department of Innovative Diabetes Therapy, Aichi Medical University School of Medicine, Nagakute 480-1185, Japan.
  • Department of Medicine, Aichi Gakuin University School of Pharmacy, Nagoya 464-8650, Japan.
  • Department of Internal Medicine, Aichi Gakuin University School of Dentistry, Nagoya 464-0821, Japan.

ORCID-Profile: Tatsuhito Himeno, Emiri Miura-Yura, Keiko Naruse, Hideki Kamiya

Zitieren

APA

Yamaguchi, M., Noda-Asano, S., Inoue, R., Himeno, T., Motegi, M., Hayami, T., Nakai-Shimoda, H., Kono, A., Sasajima, S., Miura-Yura, E., Morishita, Y., Kondo, M., Tsunekawa, S., Kato, Y., Kato, K., Naruse, K., Nakamura, J., & Kamiya, H. (2024). Dipeptidyl Peptidase (DPP)-4 Inhibitors and Pituitary Adenylate Cyclase-Activating Polypeptide, a DPP-4 Substrate, Extend Neurite Outgrowth of Mouse Dorsal Root Ganglia Neurons: A Promising Approach in Diabetic Polyneuropathy Treatment. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms25168881

Vancouver

Yamaguchi M, Noda-Asano S, Inoue R, Himeno T, Motegi M, Hayami T, et al. Dipeptidyl Peptidase (DPP)-4 Inhibitors and Pituitary Adenylate Cyclase-Activating Polypeptide, a DPP-4 Substrate, Extend Neurite Outgrowth of Mouse Dorsal Root Ganglia Neurons: A Promising Approach in Diabetic Polyneuropathy Treatment. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms25168881

BibTeX
@article{Yamaguchi2024,
  author = {Yamaguchi, Masahiro and Noda-Asano, Saeko and Inoue, Rieko and Himeno, Tatsuhito and Motegi, Mikio and Hayami, Tomohide and Nakai-Shimoda, Hiromi and Kono, Ayumi and Sasajima, Sachiko and Miura-Yura, Emiri and Morishita, Yoshiaki and Kondo, Masaki and Tsunekawa, Shin and Kato, Yoshiro and Kato, Koichi and Naruse, Keiko and Nakamura, Jiro and Kamiya, Hideki},
  title = {Dipeptidyl Peptidase (DPP)-4 Inhibitors and Pituitary Adenylate Cyclase-Activating Polypeptide, a DPP-4 Substrate, Extend Neurite Outgrowth of Mouse Dorsal Root Ganglia Neurons: A Promising Approach in Diabetic Polyneuropathy Treatment},
  journal = {International Journal of Molecular Sciences},
  year = {2024},
  doi = {10.3390/ijms25168881}
}
Kostenlos starten →